USDT Casino Bonuses-TOSPIN Online Casino & Sports Betting - Play & Bet Online

<var id="57711"></var>

<var id="57711"><tr id="57711"></tr></var>

<rt id="57711"></rt>

<mark id="57711"><object id="57711"></object></mark>

Accessibility help Skip to navigation Skip to content Skip to footer

Sunday, 27 April, 2025

Zealand Pharma says obesity drug deal with Roche will help it stay independent
Danish biotech is developing petrelintide in partnership with Swiss pharma group
Wednesday, 12 March, 2025

Roche Holding AG
Roche agrees biggest-ever obesity drug deal
Swiss pharma group signs $5.3bn licensing agreement for next-generation treatment made by Zealand Pharma
Friday, 20 December, 2024

FDA drug rejection hits Zealand Pharma shares
Treatment for short bowel syndrome fails to win approval from US regulator
Saturday, 20 July, 2024

Lex
Another Danish biotech can help investors’ hunger for obesity drugs Premium?content
The next generation of drugs vying for a slice of the potential $150bn obesity market
Monday, 26 February, 2024

Boehringer Ingelheim
Boehringer Ingelheim says weight-loss drug had positive impact on liver condition
German pharma group finds no unexpected side effects during trial, including at higher doses
Tuesday, 23 January, 2024

Drugs research
Novo Nordisk and Eli Lilly set to face new challenger in weight-loss race
Danish biotech group Zealand Pharma is developing an alternative obesity treatment to compete with big rivals
Monday, 30 June, 2014

European companies
AbbVie puts investor patience in European drugmakers to the test

Previous page 1 Next page

Subscribe for full access

<var id="ont5m"><tr id="ont5m"></tr></var>